Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Promising long-term results with proton therapy for localized prostate cancer

The value of proton therapy in managing prostate cancer is not yet defined. A recent study has reported promising long-term results for patients with localized prostate cancer who received proton therapy. However, results from ongoing clinical trials are required before determining the role of proton therapy for this indication.

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Trofimov, A. et al. Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison. Int. J. Radiat. Oncol. Biol. Phys. 69, 444–453 (2007).

    Article  Google Scholar 

  2. 2.

    Vargas, C. et al. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 70, 744–751 (2008).

    Article  Google Scholar 

  3. 3.

    Pan, H. Y. et al. Comparative toxicities and cost of intensity-modulated radiotherapy, proton radiation, and stereotactic body radiotherapy among younger men with prostate cancer. J. Clin. Oncol. 36, 1823–1830 (2018).

    CAS  Article  Google Scholar 

  4. 4.

    Xiang, M., Chang, D. T. & Pollom, E. L. Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy. Cancer 126, 3560–3568 (2020).

    Article  Google Scholar 

  5. 5.

    Suit, H. et al. Proton beams to replace photon beams in radical dose treatments. Acta. Oncol. 42, 800–808 (2003).

    Article  Google Scholar 

  6. 6.

    Takagi, M. et al. Proton therapy for localized prostate cancer: long-term results from a single-center experience. Int. J. Radiat. Oncol. Biol. Phys. (2020).

    Article  PubMed  Google Scholar 

  7. 7.

    Roach, M. 3rd et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int. J. Radiat. Oncol. Biol. Phys. 65, 965–974 (2006).

    Article  Google Scholar 

  8. 8.

    Hoppe, B. S. et al. Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. Cancer 120, 1076–1082 (2014).

    Article  Google Scholar 

  9. 9.

    Morris, W. J. et al. Androgen suppression combined with elective nodal and dose escalated radiation therapy (the ASCENDE-RT Trial): an analysis of survival endpoints for a randomized trial comparing a low-dose-rate brachytherapy boost to a dose-escalated external beam boost for high- and intermediate-risk prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 98, 275–285 (2017).

    Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Curtis M. Bryant.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Related links


PARTIQoL trial:

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bryant, C.M., Hoppe, B.S. Promising long-term results with proton therapy for localized prostate cancer. Nat Rev Urol 18, 137–138 (2021).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing